ACHE and Alzheimer disease: A 1-year follow-up study demonstrated that a group of patients with mild AD who responded to pharmacological treatment with donepezil (i.e. acetylcholinesterase inhibitors) had a lesser magnitude reduction of occipital and temporal alpha sources than their non-responder counterparts (Babiloni et al., 2006b).